LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium

An international forerunner in applying a quantitative decision-making framework throughout the drug development life cycle, Certara publicized today that LEO Pharma had licensed its proprietary Simcyp® Population-based Simulator and that the firm had become a part of its Consortium.

The Simcyp Simulator Consortium is among the most significant scientific study consortium and is one of its kind. Only recently, the Consortium cele....